Novo hunts for ‘maximum potential’ from obesity drug CagriSema
Danish group lost €90bn in market capitalisation in December after preliminary results showed it missed its target
Info Econômico – Seu Portal de Notícias Econômicas
Fonte Novo hunts for ‘maximum potential’ from obesity drug CagriSema
Procurando um novo nome de domínio? Experimente a pesquisa por nomes.